Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours. 2000

I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
Department of Urology, State Pavlov Medical University, St Petersburg, Russia. korneyev@spmu.rssi.ru

OBJECTIVE To see whether a correlation exists between clinicopathological parameters, argyrophilic nucleolar organiser regions (AgNORs), and nucleolar counts in the nuclei of tumour cells in patients with transitional cell bladder carcinoma. METHODS Paraffin wax embedded sections from a total of 62 cases of primary transitional cell bladder carcinoma were stained with the silver colloid method. The numbers of individual silver grains (AgNORs) in nucleoli and the numbers of nucleoli were counted in 100 nuclei. The correlation between AgNORs and nucleolar counts and patients' sex, tumour grade, disease stage, recurrence pattern, and tumour related survival was analysed. RESULTS The numbers of nucleoli in tumour cells were higher in male patients (p < 0.032). AgNOR numbers correlated with tumour grade (p = 0.017) and recurrence (p = 0.046). In multivariate analysis, the variation coefficient of AgNOR scores was found to be the only independent predictor of the duration of tumour free period in patients with recurrent disease (p < 0.002). AgNOR scores and nucleolar counts were of no value in distinguishing superficial and invasive tumours or in predicting tumour related survival. CONCLUSIONS AgNOR scores in transitional cell bladder carcinoma reflect variations in tumour biological behaviour; however, the clinical value of this technique in patients with urinary bladder carcinoma is limited.

UI MeSH Term Description Entries
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D009697 Nucleolus Organizer Region The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Nucleolar Organizer,Nucleolar Organizers,Nucleolus Organizer Regions,Organizer Region, Nucleolus,Organizer Regions, Nucleolus,Organizer, Nucleolar,Organizers, Nucleolar,Region, Nucleolus Organizer,Regions, Nucleolus Organizer
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D016622 Silver Staining The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens. Silver Nitrate Staining,Nitrate Staining, Silver,Staining, Silver,Staining, Silver Nitrate

Related Publications

I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
June 2001, Molecular pathology : MP,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
December 1991, British journal of cancer,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
September 1997, Journal of the Indian Medical Association,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
August 1991, British journal of cancer,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
August 1990, Journal of clinical pathology,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
June 2000, Journal of clinical pathology,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
February 1996, Clinical molecular pathology,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
June 2006, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
I A Korneyev, and N N Mamaev, and V V Kozlov, and M G Rybakova, and S H al-Shukri
March 1993, British journal of cancer,
Copied contents to your clipboard!